Purpose To review the incidence and features of vitreoretinal complications of a permanent Boston keratoprosthesis and to report the use and outcomes of 23-gauge vitrectomy to manage vitreoretinal pathology. Design Retrospective non-comparative, interventional case series.
INTRODUCTION
Use of the Boston Type 1 keratoprosthesis has increased since its approval by the Food and Drug Administration in 1992 and its recent Conformité Européene (CE) mark. It is a viable alternative to corneal transplantation in eyes with a poor prognosis for penetrating keratoplasty, including severe ocular surface disease (cicatricial pemphigoid, Stevens-Johnson syndrome, stem cell deficiency, chemical burns) or repeated corneal graft failure. [1] [2] [3] There have been continuing refinements of the anterior segment surgical techniques as well as an increasing experience in the management of complications in patients requiring Boston keratoprosthesis. This has highlighted the need for vitreoretinal expertise in the management of posterior segment complications.
Vitreoretinal surgical management of posterior segment disease in eyes with Boston KPro has been previously reported [4] [5] [6] -this has focused on the vitreoretinal techniques involved. To date, there has been a systematic report of case series which documents the incidence of posterior segment complications. 7 However, the specific clinical and immunohistological characteristics of retinal detachment in the setting of Boston Kpro have not been examined.
The purpose of this study was to review the incidence and features of vitreoretinal complications in a consecutive cohort of patients with a permanent Boston keratoprosthesis, to report clinical features of posterior segment complications and the operative management of these using 23-gauge vitrectomy and to examine the characteristics of a subretinal membrane surgically excised from an eye complicated by proliferative vitreoretinopathy (PVR) retina following the procedure. Additionally, the anatomical and functional outcomes are reported in relation to the presenting and secondary pathology.
PATIENTS AND METHODS

Moorfields Eye Hospital Research Management
Committee approval was obtained for this study. We conducted a retrospective chart review of the patients implanted with Boston keratoprosthesis at Moorfields Eye Hospital over a period of 3 years as identified from the anterior segment service database. All eyes that underwent a 23-gauge pars plana vitrectomy (PPV) and had at least 6 months follow-up were included in the analysis. Data were collected on demographic characteristics, the corneal pathology for which the eyes required keratoprosthesis implantation, the best-corrected visual acuity (BCVA) before and after keratoprosthesis, the number of previous grafts, pre-existing glaucoma or other ocular comorbidities and previous surgical intervention of glaucoma. Data on posterior segment pathology requiring surgical intervention, the BCVA before and after PPV and the intraoperative characteristics of posterior segment pathology and postoperative complications were also collected.
Surgical technique
PPV was performed in all cases using 23-gauge valved trocars placed as anteriorly as possible (ie, at the limpus) using 4 mm infusion cannulae. The binocular indirect ophthalmomicroscope (BIOM) was used as a viewing system. As a default, the wide-field BIOM lens was used, and on some occasions the 90 dioptres (0.4) BIOM lens was used if needed (see Results and Discussion sections). Perfluoro-n-octane (Perfluoron, Alcon Laboratories, Watchmore Park, Riverside Way, Camberley GU15 3YL, UK), silicone oil (1300 centistokes, Bausch & Lomb UK, Surrey KT2 6TN, England) and MembraneBlue-Dual (DORC, 3214 VN Zuidland, The Netherlands) for epiretinal membrane staining were used where appropriate.
Histological examination of subretinal membrane
A subretinal membrane excised during vitrectomy ( patient 5, tables 1 and 2) was fixed in 4% paraformaldehyde in phosphatebuffered saline ( pH 7.2), cryoprotected in 30% sucrose and embedded in optimum cutting temperature compound prior to cryostat sectioning. Sections of 12 mm thickness were immunostained using our published protocols. 8 Briefly, sections were incubated overnight at 4°C with primary antibodies, followed by three 10 min washes in Tris-buffered saline ( pH 7.5). Specific binding of primary antibodies was detected using donkey anti-IgG labelled with AlexaFluor 448 or AlexaFluor 555 (Molecular Probes, Invitrogen), reacting with the species in which the primary antibody was raised, for 2 hours at room temperature. Slides were then washed three times as above, counterstained with 4,6-diamino-2-phenylindole (DAPI) for 1 min and covered with glass cover slips using Vectashield Mounting Medium (Vector Laboratories, Burlingame, California, USA). Fluorescent images were recorded using a confocal microscope (LSM 710; Carl Zeiss, Oberkochen, Germany) operating in multitrack mode for Alexa 488, 555 and DAPI fluorochromes. Primary antibodies used in the study included antibodies to (i) the intermediate filament protein glial fibrillar acid protein (GFAP, a marker of reactive gliosis) (DAKO, UK; 1:50 dilution), (ii) cellular retinaldehyde-binding protein (CRALBP, a Müller glia and retinal pigment epithelium (RPE) cell marker) (Santa Cruz, USA; 1:200 dilution), (iii) cytokeratin 8/18 (retinal pigment epithelium (RPE) cell marker) (DAKO, UK), isolectin B4 (a microglia and endothelial cell marker) (Life Technologies, UK; 1:200 dilution) and CD68 (a macrophage and RPE cell surface marker) (DAKO, UK; 1:50 dilution).
RESULTS
Overall, 27 patients underwent Boston keratoprosthesis implantation over a period of 3 years. Of these, six required PPV (22.2%) (table 1). The mean age of the patients who underwent PPV was 63.8 years with a male to female ratio of 5:1, respectively. The mean follow-up period was 9 months (range, 6-14 months). The baseline (prior to vitrectomy) BCVA ranged from perception of light to 6/36.
In the majority of patients (five out of six cases), the posterior segment pathology that required vitrectomy followed a specific pattern. Anterior proliferation was observed from the KPro to the ciliary body/anterior retina, causing anterior (retroprosthesis) membrane formation and contraction. Hypotony was noted in these cases, although the exact intraocular pressure and the time course of the hypotony were difficult to assess with the KPro in situ. These features were combined with extensive serous/tractional anterior retinal detachment with coexistent aggressive subretinal and epiretinal proliferation. Intraoperatively, no pre-existing retinal breaks were identified in these patients. One patient (case 4) required vitreoretinal intervention for the management of a blocked Baerveldt tube ( posteriorly placed). In four cases, silicone oil was used (cases 1, 2, 5 and 6). In one case, the retina failed to reattach intraoperatively after extensive membrane peeling due to extensive PVR with epiretinal and subretinal PVR membranes (case 3). Perfluoro-N-octane was used, and it exchanged wih silicone oil. One case required three vitreoretinal procedures (including inferior retinectomy, endolaser and silicone oil injection during the last procedure) for retinal reattachment due to recurrent PVR (epiretinal and subretinal membranes) 7 months following the initial vitreoretinal intervention (case 2). In all procedures, extensive peeling of the preretinal and subretinal PVR membranes and bands was performed. Notably, in one case, the BIOM wide-field lens failed to provide adequate focus on the posterior pole, and the 90 dioptres BIOM lens had to be used for the entire length of the vitreoretinal procedure (case 3).
In two cases (3 and 5) with total retinal detachment and retroprosthetic membrane (RPM), although the trocars had been anteriorly placed at the limbus, preoperative anterior displacement of the retina resulted in sclerotomies passing initially subretinally and then through the retinal tissue to the vitreous cavity. The BCVA at the last follow-up ranged from no light perception to 6/60, and apart from case 3, all cases demonstrated attached retinae under the silicone oil at the last follow-up visit. All data and additional comments are summarised in tables 1 and 2.
Immunohistochemical features of the subretinal membrane
Immunohistochemical analysis of the subretinal membrane examined showed that this had the distinctive characteristics of a PVR membrane. This was demonstrated by its intense staining for GFAP and CRALBP, indicative of retinal glial cells. In addition, a dense infiltration of RPE cells was also observed, as judged by the strong staining for cytokeratin 8/18 staining. Intense staining for isolectin B4 and CD68 was also observed, indicating severe microglia and macrophage infiltration of the subretinal membrane (figure 1). These observations are consistent with the previous reports of PVR subretinal membranes. 9 
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DISCUSSION
The worldwide clinical experience of the use of Boston keratosprosthesis has increased, and several modifications of the device have resulted in better retention and lower complication rate.
11
There are, however, a number of significant complications occurring in the eyes which have undergone Boston KPro implantation, including RPM, 1 7 11 vitritis, 12 endophthalmitis, 7 12 Figure 1 prosthetic failure, 1 epiretinal membrane, 7 vitreous haemorrhage, 7 choroidal detachment 7 and retinal detachment. [4] [5] [6] [7] In our series, a significant incidence (22.2%) of posterior segment pathology (retinal detachment) requiring surgical management was noted. In the majority of patients (five out of six cases), we observed a specific pattern of very severe retinal detachment which resulted in profound vision loss. We noted that the eyes were hypotonous with characteristic anterior proliferation causing traction to the ciliary body and anterior retina. This resulted in extensive and significant tractional retinal detachment with significant epiretinal and subretinal PVR in all cases. It was notable that no retinal breaks were identified intraoperatively.
Although the histological features of RPMs have been previously reported, the characteristics of subretinal membranes excised from eyes complicated by PVR following Boston KPro implantation have not been documented. Unlike the negative staining for pan-cytokeratin observed in RPMs, 13 our study showed that the subretinal membrane examined exhibited a strong staining for cytokeratins 8/18, the well-known markers of RPE cells.
14 In addition, strong immunoreactivity for GFAP and CRALBP, which are markers of Müller glia and indicative of reactive retinal gliosis, was also seen. Microglial and macrophage infiltration, as judged by the intense immunostaining for isolectin B4 and CD68, was also demonstrated, which is again consistent with the inflammatory nature of PVR membranes. 15 These observations are consistent with the previous reports of PVR subretinal membranes 9 10 and confirm that a strong inflammatory response can be also elicited by Boston KPro implantation within the retina, leading to an aggressive PVR response to retinal detachment secondary to the implant procedure.
Performing posterior segment surgery in these patients can be challenging, and the information regarding the type of posterior segment pathology, the intraoperative techniques and expectations, as well as the postoperative management and prognosis have been brief in previous reports. [4] [5] [6] Kiang et al 5 reported on their experience from the use of small-gauge vitrectomy (23 procedures) in 14 eyes. Of them, seven were performed at the time of KPro placement, one included KPro removal and one was an exploratory endoscopy prior to KPro placement. In their series, the indication for PPV was the presence of RPMs in seven cases and retinal detachment in six cases. The authors have concluded that small-gauge vitrectomy can be effectively used for patients with permanent KPro. More recently, Harissi-Dagher et al 6 reported on the outcomes from the use of 20-gauge PPV (modified technique as described by Stanescu-Segall et al 16 ) in five cases. Retinal detachment was the primary indication in four cases and suprachoroidal haemorrhage from glaucoma tube overfiltration in one case. The authors concluded that PPV through KPro is a viable approach, but the visual outcome remains poor.
In our study, 23-gauge vitrectomy with valved trocars was used in all cases. We believe that the use of valved trocars is important in these cases, given the complexity of the previous history and the higher risk for intraoperative choroidal detachment/haemorrhage predisposed by intraoperative intraocular pressure fluctuations. In all cases, the trocars were placed as anteriorly as possible (ie, at the limbus) to ensure that the sclerotomies were performed at the pars plana. However, in two cases, preoperative anterior displacement of the retina resulted in sclerotomies passing through retinal tissue in order to gain access to the posterior pole. This occurrence highlights the distinct pattern of retinal detachment that was observed in our series.
All the patients in our series with retinal detachment demonstrated a variable degree of RPM. It is possible that simultaneous PPV at the time of the KPro placement, as suggested by Kiang et al, 5 may play a role in decreasing the incidence of anterior proliferation, nonetheless it may add a new set of possible complications to an already complex procedure. In addition, one of our cases (case 5) with significant tractional retinal detachment and anterior proliferation had previously undergone vitrectomy. As demonstrated in the Results section and table 2, the BCVA at the last follow-up visit ranged from 6/60 to no light perception, emphasising the poor prognosis of patients with Boston KPro requiring vitreoretinal intervention. In the future, the use of a titanium back plate for the KPro might assist in reducing RPM occurrence. It is also notable that in our series three of the six patients with severe anterior traction and retinal detachment had previously had glaucoma drainage tube surgery. This may have contributed to ongoing anterior proliferation either through lowgrade inflammation and blood ocular barrier breakdown or potentially because of chronic hypotony (which may be undiagnosed because of the presence of the KPro), contributing to the observed anterior serous retinal detachment. Two patients in our series had a drainage tube placed at the time of vitreoretinal surgery.
In our series, all vitreoretinal manoeuvres were performed without difficulty through the 23-gauge valved system with the use of BIOM as a viewing system. It is interesting that in one case we failed to achieve a good focus of the retina using the widefield lens, and the surgeon had to use the 90 dioptres BIOM lens for the full length of the procedure. In this case, all surgical steps, including fluid-air exchange, use of perfluorocarbon liquid, retinectomy, membrane removal and dissection, cryotherapy/ endolaser retinopexy and injection of silicone oil were performed using the 90-dioptre lens.
Our study has limitations due to its retrospective nature and the relatively small number of cases with retinal detachment. Nevertheless, we have identified a typical pattern of severe retinal detachment in eyes with a permanent Boston KPro, with anterior PVR extending from the KPro, and we have demonstrated the results of the histological examination of a subretinal membrane in one of our patients. We also report our experience in managing vitreoretinal complications in this group of patients.
In conclusion, 23-gauge vitrectomy can be effectively performed in patients with permanent Boston KPro. Retinal detachment in these cases seems to have specific characteristics, and the visual acuity remains poor despite successful anatomical results. Further studies are needed to explore ways of reducing and better treating post-KPro retinal detachment.
